| Autor: |
Ruggeri A; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden., De Wreede LC; Leiden University Medical Center, Leiden., Müller CR; Zentrales Knochenmarkspender-Register Deutschland, Ulm., Crivello P; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen., Bonneville EF; Leiden University Medical Center, Leiden., Petersdorf EW; Fred Hutchinson Cancer Research Center, Seattle., Socié G; Hôpital St. Louis, Paris., Dubois V; Histocompatibility Laboratory, EFS Lyon., Niittyvuopio R; HUCH Comprehensive Cancer Center, Helsinki., Peräsaari J; Clinical Laboratory Services, Histocompatibility Testing, Finnish Red Cross Blood Service, Helsinki., Yakoub-Agha I; CHU de Lille, Lille., Cornelissen JJ; Erasmus MC Cancer Institute, Rotterdam., Wieten L; Transplantation Immunology, Maastricht University Medical Center, Maastricht., Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo., Forcade E; CHU Bordeaux, Pessac., Crawley CR; Addenbrookes Hospital, Cambridge., Marsh SGE; Anthony Nolan Research Institute and UCL Cancer Institute, Royal Free Campus, London,., Gandemer V; Centre Hospitalier Universitaire de Rennes, Rennes., Tholouli E; Manchester Royal Infirmary, Manchester., Bulabois CE; CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble., Huynh A; CHU - Institut Universitaire du Cancer Toulouse, Toulouse., Choi G; University Medical Center Groningen (UMCG), Groningen., Deconinck E; Hopital Jean Minjoz, Besancon., Itäla-Remes M; Turku University Hospital, Turku., Lenhoff S; Skanes University Hospital, Lund., Bengtsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala., Johansson JE; Sahlgrenska University Hospital, Goeteborg., Van Gorkom G; University Hospital Maastricht, Maastricht., Hoogenboom JD; EBMT Leiden Study Unit, Leiden., Vago L; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden., Rocha V; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31) of the Service of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, SP., Bonini C; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden., Chabannon C; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer; Centre d'Investigations Cliniques en Biothérapie, Université d'Aix-Marseille, Inserm CBT 1409, Marseille., Fleischhauer K; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen. katharina.fleischhauer@uk-essen.de. |
